Lansoprazole/Omeprazole

兰索拉唑/奥美拉唑

Report date: 2022/11/25 17:24:36

Base Information

Drug NameLansoprazole/Omeprazole
Drug Alias Nameomeprazole+lansoprazole兰索拉唑+奥美拉唑omeprazole/lansoprazole奥美拉唑+兰索拉唑奥美拉唑/兰索拉唑 +[6] 
ClassificationSmall molecules
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsEsophageal adenocarcinomaHeartburnDyspepsia +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes LansoprazoleOmeprazole
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEffexus Pharmaceutical Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEffexus Pharmaceutical Llc
Active IndicationsN/A
Inactive IndicationsEsophageal adenocarcinomaHeartburnDyspepsia +[5] 

Other Information

ATC CodeN/A
Related LinksN/A